Genpharmasec Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue in the latest quarter (Q2 2025) rose significantly to ₹12.04 crore, indicating strong demand recovery.
Net profit improved to ₹1.22 crore in Q2 2025, a positive shift from previous losses.
Operating profit margin recovered to 4.58%, reflecting better cost management compared to earlier quarters.

NEGATIVES

Revenue dropped from ₹14.01 crore in Q1 2025 to ₹12.04 crore in Q2 2025, raising concerns about sustainability.
Profit before tax fell to ₹1.25 crore in Q2 2025 from ₹-0.43 crore in Q1 2025, indicating volatility.
Tax rate increased sharply to 2.49% in Q2 2025, affecting net profitability despite operational improvements.

Field	Mar 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	6.22	7.86	6.38	10.20	5.20	6.03	8.48	14.01	12.04
Expenses	6.01	7.90	6.37	10.21	5.02	5.91	7.75	15.01	11.10
Operating Profit	0.21	-0.04	0.02	-0.01	0.18	0.13	0.74	-1	0.94
Other Income	0.06	0.15	0.14	0.31	0.57	0.75	0.81	0.94	0.70
Interest	0.06	0.07	0.01	0.16	0.10	0.07	0.16	0.11	0.12
Depreciation	0.01	0	0.13	0.03	0.16	0.30	0.10	0.26	0.27
Profit Before Tax	0.20	0.04	0.03	0.11	0.49	0.50	1.29	-0.43	1.25
Tax	-0.84	0.04	-0.03	-0.38	0.20	-0.20	0.51	-0.15	0.03
Net Profit	1.05	0.01	0.06	0.49	0.29	0.70	0.78	-0.27	1.22
Eps in Rs	0.04	0	0	0.01	0.01	0.01	0.01	-0.01	0.02